Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer. Franks J, Caston NE, Elkhanany A, Gerke T, et al. Breast Cancer Res Treat 2022 Dec 21. doi: 10.1007/s10549-022-06823.

Read + Share

Amedeo Smart

Independent Medical Education

Franks J, Caston NE, Elkhanany A, Gerke T, et al. Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer. Breast Cancer Res Treat 2022 Dec 21. doi: 10.1007/s10549-022-06823.
PMID: 36539670